News Coverage 11.07.19 By: Arlene Weintraub Share on Twitter Share on Facebook Share on LinkedIn ASH: UPenn’s CRISPR-edited immune cells prove safe in small cancer study Related From Bench to Fireside From Metastatic Melanoma to Immune Engineering with Antoni Ribas, MD, PhD Announcement, From Bench to Fireside Dr. Elizabeth Mittendorf on breast cancer breakthroughs Announcement, From Bench to Fireside PICI’s From Bench to Fireside Podcast Returns